ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2947

Do Bone Marrow Lesions Reactivate Endochondral Ossification Leading to Osteophyte Genesis? Data from the Osteoarthritis Initiative

Leticia Deveza1, Laurence Teoh2, Elena Ochoa-Albiztegui3, Ali Guermazi4, Frank Roemer4,5 and David Hunter1, 1Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 2Department of General Medicine, Middlemore Hospital, Auckland, New Zealand, Auckland, New Zealand, 3Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, New York, NY, 4Department of Radiology, Boston University School of Medicine, Boston, MA, USA, Boston, MA, 5Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: bone marrow lesions, MRI, osteoarthritis and osteophytosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Osteoarthritis – Clinical Aspects II: Structural Progression and Incidence

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Osteophytes are formed through reactivation of endochondral ossification. In adults, reactivation of endochondral ossification may occur in the context of fracture repair. As yet, the rationale for the genesis of osteophytes in osteoarthritis (OA) remains unclear. We investigated whether bone marrow lesions (BMLs) (representing subchondral remodeling due to increased loading) and inflammation (assessed as effusion-synovitis on non-contrast-enhanced MRI) were associated with the presence and progression of osteophytes in OA knees.

Methods: We analyzed data from 600 participants included in the FNIH Biomarkers study within the Osteoarthritis Initiative. Osteophytes and BMLs were scored according to size (0-3) on MRI in the medial and lateral femur and tibia, and effusion-synovitis was scored in the whole knee according to severity (0-3, where 0 means absent) using the MRI OA Knee Score (MOAKS). BMLs and effusion-synovitis were considered present when a score ≥ 1 for each feature was given. Osteophyte severity was categorized into grades 0 (absent), 1 (small) and 2-3 (medium to large). We examined the cross-sectional and longitudinal relation between the baseline presence of BMLs and effusion-synovitis to osteophyte severity and progression (increase in size in ≥ 1 grade) in each joint compartment on MRI over 24 months. Ordinal regression was used for the cross-sectional analysis and binary logistic regression for the longitudinal analysis adjusted for covariates. We assessed the interaction effect between BMLs and knee alignment, measured by goniometer on physical examination (neutral, varus or valgus), using interaction terms.

Results: At baseline, BMLs were present in 10.8% to 53.3% depending on the knee compartment and effusion-synovitis was present in 61% of the knees. Presence of BMLs was strongly associated with baseline osteophytes in all four knee compartments (Table), with odds ratios (OR) ranging from 1.63 (95% confidence interval [CI] 1.15, 2.30) in the medial femur to 7.13 (4.92, 10.93) in the lateral femur. Presence of effusion-synovitis was also associated with osteophytes, except in the medial tibia. At baseline, the interaction analysis showed no effect of alignment in the association between BMLs and osteophytes. Over 24 months, osteophyte progression mostly occurred in the medial tibia (7.3%) and was strongly associated with the presence of baseline BMLs in the same joint compartment (OR 3.89 [1.84, 8.23]). Baseline effusion-synovitis was also associated with an increase in osteophyte size in the medial femur and tibia.

Conclusion: Bone marrow lesions were strongly associated with the presence of osteophytes and with osteophyte progression on MRI over 24 months. Although inflammation may also play a role in the development of osteophytes, BMLs appear to be more strongly related to the reactivation of endochondral ossification process.


Disclosure: L. Deveza, None; L. Teoh, None; E. Ochoa-Albiztegui, None; A. Guermazi, BICL, LLC, 1,MerckSerono, TissueGene, OrthoTrophix, AstraZeneca and Genzyme, 5; F. Roemer, None; D. Hunter, Flexion, Merck Serono, Tissuegene, 5,DJO, 7.

To cite this abstract in AMA style:

Deveza L, Teoh L, Ochoa-Albiztegui E, Guermazi A, Roemer F, Hunter D. Do Bone Marrow Lesions Reactivate Endochondral Ossification Leading to Osteophyte Genesis? Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/do-bone-marrow-lesions-reactivate-endochondral-ossification-leading-to-osteophyte-genesis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-bone-marrow-lesions-reactivate-endochondral-ossification-leading-to-osteophyte-genesis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology